Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Jan 08, 2018

SELL
$93.56 - $116.6 $533,104 - $664,386
-5,698 Closed
0 $0
Q3 2017

Oct 06, 2017

BUY
$109.15 - $138.27 $621,936 - $787,862
5,698
5,698 $665,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Century Link Investment Management CO Portfolio

Follow Century Link Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Century Link Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Century Link Investment Management CO with notifications on news.